Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease

被引:17
|
作者
Jung, Seung-Jin [1 ]
Park, Seung-Hwan [2 ]
Lee, Eun Je [1 ]
Park, Jeong Hoon [1 ]
Kong, Young Bae [1 ]
Rho, Jong Kook [1 ]
Hur, Min Goo [1 ]
Yang, Seung Dae [1 ]
Park, Yong Dae [1 ,2 ]
机构
[1] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongup 580185, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Dept Nucl Med, Hwasun, South Korea
关键词
Alzheimer's disease (AD); A beta plaques; Fluorescent probe; Chalcone-mimic probes; IN-VIVO; IMAGING AGENT; DESIGN; BRAIN; DERIVATIVES; CHALCONES; DEPOSITS;
D O I
10.1007/s12272-015-0617-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
beta-amyloid (A beta) plaques in the brain are composed of A beta(40) and A beta(42) peptides, and are the defining pathological feature of Alzheimer's disease (AD). Fluorescent probes that can detect A beta plaques have gained increasing interest as potential tools for in vitro and in vivo monitoring of the progression of AD. In this study, chalcone-mimic fluorescent probe 5 was designed and prepared. Probe 5 exhibited an approximately 50-fold increase in emission intensity after mixing with A beta(42) aggregates, a high affinity for A beta(42) aggregates (K (D) = 1.59 mu M), and reasonable lipophilicity (log P value = 2.55). Probe 5 also exhibited specific staining of A beta plaques in the transgenic mice (APP/PS1) brain sections. Ex vivo fluorescence imaging of the brain from normal and TG mice revealed that probe 5 was able to penetrate the BBB and stain the A beta plaques. These results suggest that chalcone-mimic probe 5 possessed the requirements of a fluorescent probe for A beta plaques and may be useful in AD research.
引用
收藏
页码:1992 / 1998
页数:7
相关论文
共 50 条
  • [1] Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer’s disease
    Seung-Jin Jung
    Seung-Hwan Park
    Eun Je Lee
    Jeong Hoon Park
    Young Bae Kong
    Jong Kook Rho
    Min Goo Hur
    Seung Dae Yang
    Yong Dae Park
    Archives of Pharmacal Research, 2015, 38 : 1992 - 1998
  • [2] ANCA: A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue
    Chang, Willy M.
    Dakanali, Marianna
    Capule, Christina C.
    Sigurdson, Christina J.
    Yang, Jerry
    T'heodorakis, Emmanuel A.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (05): : 249 - 255
  • [3] Probes for amyloid plaques in Alzheimer's disease
    Kung, MP
    Zhuang, ZP
    Skovronsky, DM
    Hou, C
    Zhang, B
    Lee, VMY
    Trojanowski, JQ
    Kung, HF
    NEUROBIOLOGY OF AGING, 2001, 22 (02) : 335 - 335
  • [4] Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer's disease
    Hongjuan Tong
    Kaiyan Lou
    Wei Wang
    Acta Pharmaceutica Sinica B, 2015, 5 (01) : 25 - 33
  • [5] Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer's disease
    Tong, Hongjuan
    Lou, Kaiyan
    Wang, Wei
    ACTA PHARMACEUTICA SINICA B, 2015, 5 (01) : 25 - 33
  • [6] Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease
    Leskovjan, Andreana C.
    Lanzirotti, Antonio
    Miller, Lisa M.
    NEUROIMAGE, 2009, 47 (04) : 1215 - 1220
  • [7] Aurones serve as probes of P-amyloid plaques in Alzheimer's disease
    Ono, Masahiro
    Maya, Yoshifumi
    Haratake, Mamoru
    Ito, Kazuhiro
    Mori, Hiroshi
    Nakayama, Morio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (01) : 116 - 121
  • [8] Discovery of boronic acid-based fluorescent probes targeting amyloid-beta plaques in Alzheimer's disease
    Jung, Seung-Jin
    Lee, Jun Young
    Kim, Tae Ho
    Lee, Dong-Eun
    Jeon, Jongho
    Yang, Seung Dae
    Hur, Min Goo
    Min, Jung-Joon
    Park, Yong Dae
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (07) : 1784 - 1788
  • [9] β-amyloid Peptides and Amyloid Plaques in Alzheimer’s Disease
    Gunnar K. Gouras
    Tomas T. Olsson
    Oskar Hansson
    Neurotherapeutics, 2015, 12 : 3 - 11
  • [10] β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
    Gouras, Gunnar K.
    Olsson, Tomas T.
    Hansson, Oskar
    NEUROTHERAPEUTICS, 2015, 12 (01) : 3 - 11